One of the most significant differences in prenatal care for women over 35 is the broader menu of genetic screening and diagnostic testing available—and often recommended. Navigating these options can feel overwhelming, particularly early in pregnancy when emotions are already running high. Understanding what each test does, what it can and cannot tell you, and how to approach decision-making can help make this aspect of pregnancy after 35 feel less daunting.
It’s worth noting at the outset that the term “advanced maternal age” (AMA)—applied to pregnancies in women 35 and older—doesn’t mean a high-risk pregnancy is inevitable. The vast majority of pregnancies after 35 proceed healthily. What does change is the statistical likelihood of certain chromosomal conditions, which is why additional testing options are routinely discussed.
Genetic testing in pregnancy falls into two broad categories: screening tests, which assess probability, and diagnostic tests, which provide more definitive information. Understanding the distinction between these is foundational to informed decision-making.
What Changes Genetically After 35
The increase in chromosomal abnormalities with maternal age is one of the most well-documented findings in reproductive medicine. According to the American College of Obstetricians and Gynecologists (ACOG), the likelihood of conceiving a pregnancy with a chromosomal condition such as Down syndrome increases with age. At age 35, the risk of a chromosomal abnormality in a recognized pregnancy is estimated at roughly 1 in 200; by age 40, this risk is approximately 1 in 65.
While these numbers represent a real increase, it’s equally important to recognize that the majority of pregnancies—even at older maternal ages—do not involve chromosomal abnormalities. Statistics describe population-level probabilities, not individual outcomes. This is where prenatal testing can be valuable: it provides more specific information about a particular pregnancy.
Screening Tests: Understanding Probability
Screening tests are non-invasive and carry no procedural risk to the pregnancy. They assess the probability of certain chromosomal conditions but do not provide a definitive diagnosis. A “positive” or “high-risk” screen means the probability is higher than average—not that the condition is present.
Cell-Free DNA Screening (cfDNA / NIPT)
Cell-free DNA screening, also called non-invasive prenatal testing (NIPT), analyzes fragments of placental DNA circulating in the mother’s blood. It can be performed as early as 10 weeks of pregnancy and screens primarily for chromosomal conditions including Down syndrome (trisomy 21), trisomy 18, trisomy 13, and sex chromosome abnormalities. For women over 35, research suggests cfDNA has higher sensitivity and specificity than first-trimester combined screening. A positive result on cfDNA is typically followed by diagnostic testing for confirmation.
First-Trimester Combined Screening
This screening combines a blood test (measuring pregnancy-associated plasma protein-A and human chorionic gonadotropin) with a nuchal translucency ultrasound, which measures fluid at the back of the baby’s neck. Performed between 10 and 14 weeks, this combination provides a probability assessment for Down syndrome and trisomy 18.
Second-Trimester Serum Screening
Also known as the quad screen or AFP test, second-trimester serum screening measures four markers in maternal blood to assess probability of chromosomal conditions and neural tube defects. It can be used alone or integrated with first-trimester results for a combined assessment.
Diagnostic Tests: More Definitive Information
Diagnostic tests can provide more definitive chromosomal information but involve procedures that carry a small risk of pregnancy complications. These tests are typically offered to women with high-risk screening results, a previous pregnancy affected by a chromosomal condition, or other specific risk factors.
Chorionic Villus Sampling (CVS)
CVS involves sampling a small amount of placental tissue, typically performed between 10 and 13 weeks. It can diagnose chromosomal conditions and some genetic disorders. The procedure-related miscarriage risk is generally estimated at less than 1% in experienced hands, though individual provider and facility experience matters.
Amniocentesis
Amniocentesis involves sampling amniotic fluid and is typically performed between 15 and 20 weeks. It can diagnose a wide range of chromosomal and genetic conditions. The procedure-related miscarriage risk is similarly estimated at less than 1% in experienced facilities, according to ACOG guidance.
Deciding Which Tests Are Right for You
Decisions about genetic testing during pregnancy are deeply personal and should reflect individual values, circumstances, and what information would be meaningful and useful. Some women find that knowing is important to them—whether for decision-making about the pregnancy, for preparation, or simply for peace of mind. Others prefer not to pursue testing beyond what feels necessary. Neither approach is inherently right or wrong.
ACOG guidance indicates that all pregnant women—regardless of age—should be offered the option of prenatal genetic screening and diagnostic testing. For women over 35, these conversations typically happen earlier and in more detail.
Working with your OB/GYN or maternal-fetal medicine specialist to understand what each test can and cannot tell you and how results would affect your decisions and care is the most meaningful starting point.
After a Screening Result: What Comes Next
A high-risk or “positive” screening result can provoke significant anxiety. It’s important to remember that screening tests report probabilities, not diagnoses—and a high-risk screen does not confirm a chromosomal condition. The next step is typically a consultation with a genetic counselor and a discussion about whether diagnostic testing is appropriate.
Genetic counselors are specially trained to help individuals and families understand the implications of genetic testing results, discuss options, and navigate next steps in an emotionally supportive way. Many women find these consultations invaluable during an uncertain time.
Frequently Asked Questions
Is prenatal genetic testing mandatory after 35?
No—prenatal genetic testing is offered, not required. The decision to pursue any form of testing is personal, and current guidelines support informed decision-making rather than mandatory testing. A conversation with your OB/GYN can help you understand your options.
What is the difference between screening and diagnostic testing?
Screening tests assess probability and carry no procedural risk; a positive result means increased probability, not confirmation. Diagnostic tests (CVS or amniocentesis) can provide definitive chromosomal information but involve a small procedural risk. Most high-risk screening results are followed by diagnostic testing for confirmation.
If my cfDNA (NIPT) is negative, does that mean everything is fine?
A negative cfDNA result significantly reduces the probability of the specific conditions screened, but it does not rule out all chromosomal abnormalities or other conditions. No test screens for everything. Your healthcare provider can explain exactly what a negative result does and does not mean in your specific situation.
When should I see a genetic counselor?
A genetic counselor may be recommended before testing (to help you decide what’s right for you), after a high-risk screening result, if you have a family history of genetic conditions, or following a positive diagnostic test result. Many women find genetic counseling helpful at any point in the process.
Key Takeaways
- Prenatal genetic testing options include non-invasive screening tests and more definitive diagnostic procedures—each with distinct purposes and risk profiles.
- Cell-free DNA (NIPT) is generally considered the most sensitive screening test for common chromosomal conditions and can be performed as early as 10 weeks.
- A positive screening result indicates increased probability—not a confirmed diagnosis—and is typically followed by diagnostic testing.
- Decisions about genetic testing are personal and should reflect individual values and circumstances; genetic counselors can provide valuable guidance.
- Working closely with your OB/GYN or maternal-fetal medicine specialist ensures testing decisions are well-informed and tailored to your situation.
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.